United States Biotechnology & Medical Research

Endocyte Inc (ECYT)

Track

Track

Ticker: ECYT Exchange: NSM
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
No insider activity signals detected

Insider trades have not triggered unusual activity signals for this company.

Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Andriole Michael T. Chief Financial Officer Officer
Transaction date
Planned sale
Price
492.21
Quantity 26,922 +21.2%
Value US$4,334,698
Low Philip S Chief Science Officer Executive Director
Transaction date
Planned sale
Price
455.39
Quantity 13,810 +25.5%
Value US$3,070,057
Armour Alison A. Chief Medical Officer Officer
Transaction date
Planned sale
Price
39.60
Quantity 47,560 +48.2%
Value US$2,116,211
Taylor Beth VP Finance & Chief Acctg Offcr Officer
Transaction date
Planned sale
Price
15.56
Quantity 7,022 -11.1%
Value US$109,287
Leamon Christopher P Vice President of Research Officer
Transaction date
Planned sale
Price
15.56
Quantity 9,028 -6.9%
Value US$140,437
Andriole Michael T. Chief Financial Officer Officer
Transaction date
Planned sale
Price
15.55
Quantity 17,283 -11.5%
Value US$268,783
Sherman Michael A. President and CEO Executive Director
Transaction date
Planned sale
Price
15.55
Quantity 28,146 -7.5%
Value US$437,752
Chelius Erik C. Vice President CMC Officer
Transaction date
Planned sale
Price
15.56
Quantity 4,514 -8.3%
Value US$70,243
Parker Katherine VP of Human Resources Officer
Transaction date
Planned sale
Price
15.55
Quantity 6,771 -8.8%
Value US$105,316
Leamon Christopher P Vice President of Research Officer
Transaction date
Planned sale
Price
20.00
Quantity 4,696 -3.5%
Value US$93,920
Taylor Beth VP Finance & Chief Acctg Offcr Officer
Transaction date
Planned sale
Price
20.00
Quantity 7,892 -11.1%
Value US$157,840
Leamon Christopher P Vice President of Research Officer
Transaction date
Planned sale
Price
20.00
Quantity 12,670 -8.9%
Value US$253,403
Taylor Beth VP Finance & Chief Acctg Offcr Officer
Transaction date
Planned sale
Price
18.20
Quantity 285 -0.4%
Value US$5,187
Armour Alison A. Chief Medical Officer Officer
Transaction date
Planned sale
Price
15.98
Quantity 1,414 -1.3%
Value US$22,589
Leamon Christopher P Vice President of Research
Transaction date
Planned sale
Price
15.06
Quantity 13,089 -9.1%
Value US$197,058
Leamon Christopher P Vice President of Research
Transaction date
Planned sale
Price
9.07
Quantity 5,036 -3.4%
Value US$45,677
Low Philip S Chief Science Officer Executive Director
Transaction date
Sale
Price
4.41
Quantity 50,511 -14.3%
Value US$222,824
Leamon Christopher P Vice President of Research
Transaction date
Sale
Price
5.05
Quantity 5,037 -3.8%
Value US$25,434
Leamon Christopher P Vice President of Research
Transaction date
Sale
Price
5.03
Quantity 18,194 -12.1%
Value US$91,549
Low Philip S Chief Science Officer Executive Director
Transaction date
Purchase
Price
4.84
Quantity 5,600 +2.0%
Value US$27,104
Leamon Christopher P Vice President of Research Officer
Transaction date
Sale
Price
2.55
Quantity 23,244 -25.8%
Value US$59,272
Low Philip S Chief Science Officer Executive Director
Transaction date
Purchase
Price
3.52
Quantity 11,375 +5.5%
Value US$40,040
MIDDLETON FRED A Non-Executive Director
Transaction date
Purchase
Price
2.79
Quantity 10,000 +5.2%
Value US$27,900
MIDDLETON FRED A Non-Executive Director
Transaction date
Purchase
Price
2.80
Quantity 20,000 +11.7%
Value US$56,000
Nguyen Binh VP of Medical Affairs Officer
Transaction date
Sale
Price
5.79
Quantity 29,883 -51.3%
Value US$172,987
Lovejoy Chandra D VP of Regulatory Affairs Officer
Transaction date
Planned sale
Price
7.00
Quantity 21,479 -77.5%
Value US$150,353
Meek David D. Chief Commercial Officer Officer
Transaction date
Sale
Price
15.50
Quantity 10,000 -100.0%
Value US$155,000
Ritter Allen R VP of Manufacturing/CMC Officer
Transaction date
Sale
Price
14.36
Quantity 6,000 -25.3%
Value US$86,160
Lovejoy Chandra D VP of Regulatory Affairs Officer
Transaction date
Sale
Price
17.29
Quantity 7,000 -100.0%
Value US$121,030
HANHAM ANN Non-Executive Director
Transaction date
Sale
Price
14.25
Quantity 131 -0.2%
Value US$1,867
HANHAM ANN Non-Executive Director
Transaction date
Sale
Price
14.25
Quantity 1,569 -0.2%
Value US$22,358
HANHAM ANN Non-Executive Director
Transaction date
Sale
Price
14.07
Quantity 630 -1.1%
Value US$8,864
HANHAM ANN Non-Executive Director
Transaction date
Sale
Price
14.07
Quantity 7,570 -1.1%
Value US$106,510
HANHAM ANN Non-Executive Director
Transaction date
Sale
Price
14.39
Quantity 1,259 -2.2%
Value US$18,117
HANHAM ANN Non-Executive Director
Transaction date
Sale
Price
14.39
Quantity 15,141 -2.2%
Value US$217,879
HANHAM ANN Non-Executive Director
Transaction date
Sale
Price
14.31
Quantity 845 -1.5%
Value US$12,092
HANHAM ANN Non-Executive Director
Transaction date
Sale
Price
14.31
Quantity 10,155 -1.5%
Value US$145,318
HANHAM ANN Non-Executive Director
Transaction date
Sale
Price
14.42
Quantity 967 -1.7%
Value US$13,944
HANHAM ANN Non-Executive Director
Transaction date
Sale
Price
14.42
Quantity 11,633 -1.7%
Value US$167,748
Nguyen Binh VP of Clinical Affairs Officer
Transaction date
Sale
Price
14.42
Quantity 17,300 -100.0%
Value US$249,466
HANHAM ANN Non-Executive Director
Transaction date
Sale
Price
14.37
Quantity 1,121 -1.9%
Value US$16,109
HANHAM ANN Non-Executive Director
Transaction date
Sale
Price
14.37
Quantity 13,479 -1.9%
Value US$193,693
HANHAM ANN Non-Executive Director
Transaction date
Sale
Price
14.44
Quantity 1,735 -2.9%
Value US$25,053
HANHAM ANN Non-Executive Director
Transaction date
Sale
Price
14.44
Quantity 20,865 -2.9%
Value US$301,291
HANHAM ANN Non-Executive Director
Transaction date
Sale
Price
14.43
Quantity 1,536 -2.5%
Value US$22,164
HANHAM ANN Non-Executive Director
Transaction date
Sale
Price
14.43
Quantity 18,464 -2.5%
Value US$266,436
HANHAM ANN Non-Executive Director
Transaction date
Sale
Price
14.94
Quantity 1,551 -2.4%
Value US$23,172
HANHAM ANN Non-Executive Director
Transaction date
Sale
Price
14.94
Quantity 18,649 -2.4%
Value US$278,616
Leamon Christopher P Vice President of Research Officer
Transaction date
Sale
Price
14.70
Quantity 5,000 -33.2%
Value US$73,500
Lovejoy Chandra D VP of Regulatory Affairs Officer
Transaction date
Planned sale
Price
9.70
Quantity 1,993 -100.0%
Value US$19,332
Lovejoy Chandra D VP of Regulatory Affairs Officer
Transaction date
Planned sale
Price
9.70
Quantity 109 -100.0%
Value US$1,057
Ritter Allen R VP of Manufacturing/CMC Officer
Transaction date
Planned sale
Price
10.03
Quantity 500 -14.4%
Value US$5,015
Lovejoy Chandra D VP of Regulatory Affairs Officer
Transaction date
Planned sale
Price
9.56
Quantity 1,659 -100.0%
Value US$15,860
Lovejoy Chandra D VP of Regulatory Affairs Officer
Transaction date
Planned sale
Price
9.56
Quantity 443 -100.0%
Value US$4,235
Lovejoy Chandra D VP of Regulatory Affairs Officer
Transaction date
Planned sale
Price
9.56
Quantity 107 -100.0%
Value US$1,023
Lovejoy Chandra D VP of Regulatory Affairs Officer
Transaction date
Planned sale
Price
9.05
Quantity 2,102 -100.0%
Value US$19,023
Lovejoy Chandra D VP of Regulatory Affairs Officer
Transaction date
Planned sale
Price
9.05
Quantity 107 -100.0%
Value US$968
Lovejoy Chandra D VP of Regulatory Affairs Officer
Transaction date
Planned sale
Price
8.72
Quantity 1,926 -100.0%
Value US$16,795
Lovejoy Chandra D VP of Regulatory Affairs Officer
Transaction date
Planned sale
Price
8.72
Quantity 283 -100.0%
Value US$2,468
Lovejoy Chandra D VP of Regulatory Affairs Officer
Transaction date
Planned sale
Price
9.71
Quantity 2,209 -100.0%
Value US$21,449
Low Philip S Chief Science Officer Executive Director
Transaction date
Sale
Price
9.99
Quantity 34,000 -8.1%
Value US$339,810
Lovejoy Chandra D VP of Regulatory Affairs Officer
Transaction date
Planned sale
Price
10.28
Quantity 2,209 -100.0%
Value US$22,709
Leamon Christopher P Vice President of Research Officer
Transaction date
Sale
Price
9.65
Quantity 10,000 -39.9%
Value US$96,535
HANHAM ANN Non-Executive Director
Transaction date
Sale
Price
6.60
Quantity 24,181 -27.4%
Value US$159,674
HANHAM ANN Non-Executive Director
Transaction date
Sale
Price
6.60
Quantity 290,719 -27.4%
Value US$1,919,705
HANHAM ANN Non-Executive Director
Transaction date
Sale
Price
6.60
Quantity 783 -0.9%
Value US$5,170
HANHAM ANN Non-Executive Director
Transaction date
Sale
Price
6.60
Quantity 9,417 -0.9%
Value US$62,180
HANHAM ANN Non-Executive Director
Transaction date
Sale
Price
6.65
Quantity 2,142 -2.3%
Value US$14,246
HANHAM ANN Non-Executive Director
Transaction date
Sale
Price
6.65
Quantity 25,758 -2.3%
Value US$171,306
HANHAM ANN Non-Executive Director
Transaction date
Sale
Price
6.68
Quantity 3,071 -3.3%
Value US$20,510
HANHAM ANN Non-Executive Director
Transaction date
Sale
Price
6.68
Quantity 36,929 -3.3%
Value US$246,638
HANHAM ANN Non-Executive Director
Transaction date
Sale
Price
6.94
Quantity 8,215 -8.0%
Value US$56,974
HANHAM ANN Non-Executive Director
Transaction date
Sale
Price
6.94
Quantity 98,785 -8.0%
Value US$685,113
SANDERLING VENTURES MANAGEMENT V Large shareholder
Transaction date
Purchase
Price
3.16
Quantity 2,200 +6.7%
Value US$6,952
Sanderling Venture Partners V, LP Large shareholder
Transaction date
Purchase
Price
3.16
Quantity 217,800 +33.3%
Value US$688,248
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2018-10-09 2018-10-09 PlS Planned sale Andriole Michael T.

Chief Financial Officer

Officer
26,922 +21.2%
492.21
US$4,334,698 		26,922 +21.2% 492.21 US$4,334,698
2018-10-09 2018-10-05 PlS Planned sale Low Philip S

Chief Science Officer

Executive Director
13,810 +25.5%
455.39
US$3,070,057 		13,810 +25.5% 455.39 US$3,070,057
2018-10-09 2018-10-05 PlS Planned sale Armour Alison A.

Chief Medical Officer

Officer
47,560 +48.2%
39.60
US$2,116,211 		47,560 +48.2% 39.60 US$2,116,211
2018-10-09 2018-10-05 PlS Planned sale Taylor Beth

VP Finance & Chief Acctg Offcr

Officer
7,022 -11.1%
15.56
US$109,287 		7,022 -11.1% 15.56 US$109,287
2018-10-09 2018-10-05 PlS Planned sale Leamon Christopher P

Vice President of Research

Officer
9,028 -6.9%
15.56
US$140,437 		9,028 -6.9% 15.56 US$140,437
2018-10-09 2018-10-05 PlS Planned sale Andriole Michael T.

Chief Financial Officer

Officer
17,283 -11.5%
15.55
US$268,783 		17,283 -11.5% 15.55 US$268,783
2018-10-09 2018-10-05 PlS Planned sale Sherman Michael A.

President and CEO

Executive Director
28,146 -7.5%
15.55
US$437,752 		28,146 -7.5% 15.55 US$437,752
2018-10-09 2018-10-05 PlS Planned sale Chelius Erik C.

Vice President CMC

Officer
4,514 -8.3%
15.56
US$70,243 		4,514 -8.3% 15.56 US$70,243
2018-10-09 2018-10-05 PlS Planned sale Parker Katherine

VP of Human Resources

Officer
6,771 -8.8%
15.55
US$105,316 		6,771 -8.8% 15.55 US$105,316
2018-08-29 2018-08-29 PlS Planned sale Leamon Christopher P

Vice President of Research

Officer
4,696 -3.5%
20.00
US$93,920 		4,696 -3.5% 20.00 US$93,920
2018-08-29 2018-08-28 PlS Planned sale Taylor Beth

VP Finance & Chief Acctg Offcr

Officer
7,892 -11.1%
20.00
US$157,840 		7,892 -11.1% 20.00 US$157,840
2018-08-29 2018-08-28 PlS Planned sale Leamon Christopher P

Vice President of Research

Officer
12,670 -8.9%
20.00
US$253,403 		12,670 -8.9% 20.00 US$253,403
2018-08-22 2018-08-20 PlS Planned sale Taylor Beth

VP Finance & Chief Acctg Offcr

Officer
285 -0.4%
18.20
US$5,187 		285 -0.4% 18.20 US$5,187
2018-08-02 2018-08-01 PlS Planned sale Armour Alison A.

Chief Medical Officer

Officer
1,414 -1.3%
15.98
US$22,589 		1,414 -1.3% 15.98 US$22,589
2018-06-13 2018-06-12 PlS Planned sale Leamon Christopher P

Vice President of Research
13,089 -9.1%
15.06
US$197,058 		13,089 -9.1% 15.06 US$197,058
2018-03-12 2018-03-09 PlS Planned sale Leamon Christopher P

Vice President of Research
5,036 -3.4%
9.07
US$45,677 		5,036 -3.4% 9.07 US$45,677
2018-01-02 2017-12-28 S Sale Low Philip S

Chief Science Officer

Executive Director
50,511 -14.3%
4.41
US$222,824 		50,511 -14.3% 4.41 US$222,824
2017-12-04 2017-12-01 S Sale Leamon Christopher P

Vice President of Research
5,037 -3.8%
5.05
US$25,434 		5,037 -3.8% 5.05 US$25,434
2017-12-04 2017-12-01 S Sale Leamon Christopher P

Vice President of Research
18,194 -12.1%
5.03
US$91,549 		18,194 -12.1% 5.03 US$91,549
2017-11-14 2017-11-13 B Purchase Low Philip S

Chief Science Officer

Executive Director
5,600 +2.0%
4.84
US$27,104 		5,600 +2.0% 4.84 US$27,104
2017-01-04 2016-12-30 S Sale Leamon Christopher P

Vice President of Research

Officer
23,244 -25.8%
2.55
US$59,272 		23,244 -25.8% 2.55 US$59,272
2016-05-12 2016-05-10 B Purchase Low Philip S

Chief Science Officer

Executive Director
11,375 +5.5%
3.52
US$40,040 		11,375 +5.5% 3.52 US$40,040
2016-01-20 2016-01-19 B Purchase MIDDLETON FRED A Non-Executive Director
10,000 +5.2%
2.79
US$27,900 		10,000 +5.2% 2.79 US$27,900
2016-01-20 2016-01-15 B Purchase MIDDLETON FRED A Non-Executive Director
20,000 +11.7%
2.80
US$56,000 		20,000 +11.7% 2.80 US$56,000
2015-03-05 2015-03-03 S Sale Nguyen Binh

VP of Medical Affairs

Officer
29,883 -51.3%
5.79
US$172,987 		29,883 -51.3% 5.79 US$172,987
2014-08-13 2014-08-11 PlS Planned sale Lovejoy Chandra D

VP of Regulatory Affairs

Officer
21,479 -77.5%
7.00
US$150,353 		21,479 -77.5% 7.00 US$150,353
2013-09-16 2013-09-12 S Sale Meek David D.

Chief Commercial Officer

Officer
10,000 -100.0%
15.50
US$155,000 		10,000 -100.0% 15.50 US$155,000
2013-09-04 2013-08-30 S Sale Ritter Allen R

VP of Manufacturing/CMC

Officer
6,000 -25.3%
14.36
US$86,160 		6,000 -25.3% 14.36 US$86,160
2013-08-08 2013-08-06 S Sale Lovejoy Chandra D

VP of Regulatory Affairs

Officer
7,000 -100.0%
17.29
US$121,030 		7,000 -100.0% 17.29 US$121,030
2013-05-29 2013-05-28 S Sale HANHAM ANN Non-Executive Director
131 -0.2%
14.25
US$1,867 		131 -0.2% 14.25 US$1,867
2013-05-29 2013-05-28 S Sale HANHAM ANN Non-Executive Director
1,569 -0.2%
14.25
US$22,358 		1,569 -0.2% 14.25 US$22,358
2013-05-29 2013-05-24 S Sale HANHAM ANN Non-Executive Director
630 -1.1%
14.07
US$8,864 		630 -1.1% 14.07 US$8,864
2013-05-29 2013-05-24 S Sale HANHAM ANN Non-Executive Director
7,570 -1.1%
14.07
US$106,510 		7,570 -1.1% 14.07 US$106,510
2013-05-22 2013-05-22 S Sale HANHAM ANN Non-Executive Director
1,259 -2.2%
14.39
US$18,117 		1,259 -2.2% 14.39 US$18,117
2013-05-22 2013-05-22 S Sale HANHAM ANN Non-Executive Director
15,141 -2.2%
14.39
US$217,879 		15,141 -2.2% 14.39 US$217,879
2013-05-22 2013-05-21 S Sale HANHAM ANN Non-Executive Director
845 -1.5%
14.31
US$12,092 		845 -1.5% 14.31 US$12,092
2013-05-22 2013-05-21 S Sale HANHAM ANN Non-Executive Director
10,155 -1.5%
14.31
US$145,318 		10,155 -1.5% 14.31 US$145,318
2013-05-22 2013-05-20 S Sale HANHAM ANN Non-Executive Director
967 -1.7%
14.42
US$13,944 		967 -1.7% 14.42 US$13,944
2013-05-22 2013-05-20 S Sale HANHAM ANN Non-Executive Director
11,633 -1.7%
14.42
US$167,748 		11,633 -1.7% 14.42 US$167,748
2013-05-21 2013-05-17 S Sale Nguyen Binh

VP of Clinical Affairs

Officer
17,300 -100.0%
14.42
US$249,466 		17,300 -100.0% 14.42 US$249,466
2013-05-20 2013-05-17 S Sale HANHAM ANN Non-Executive Director
1,121 -1.9%
14.37
US$16,109 		1,121 -1.9% 14.37 US$16,109
2013-05-20 2013-05-17 S Sale HANHAM ANN Non-Executive Director
13,479 -1.9%
14.37
US$193,693 		13,479 -1.9% 14.37 US$193,693
2013-05-20 2013-05-16 S Sale HANHAM ANN Non-Executive Director
1,735 -2.9%
14.44
US$25,053 		1,735 -2.9% 14.44 US$25,053
2013-05-20 2013-05-16 S Sale HANHAM ANN Non-Executive Director
20,865 -2.9%
14.44
US$301,291 		20,865 -2.9% 14.44 US$301,291
2013-05-16 2013-05-15 S Sale HANHAM ANN Non-Executive Director
1,536 -2.5%
14.43
US$22,164 		1,536 -2.5% 14.43 US$22,164
2013-05-16 2013-05-15 S Sale HANHAM ANN Non-Executive Director
18,464 -2.5%
14.43
US$266,436 		18,464 -2.5% 14.43 US$266,436
2013-05-16 2013-05-14 S Sale HANHAM ANN Non-Executive Director
1,551 -2.4%
14.94
US$23,172 		1,551 -2.4% 14.94 US$23,172
2013-05-16 2013-05-14 S Sale HANHAM ANN Non-Executive Director
18,649 -2.4%
14.94
US$278,616 		18,649 -2.4% 14.94 US$278,616
2013-05-16 2013-05-14 S Sale Leamon Christopher P

Vice President of Research

Officer
5,000 -33.2%
14.70
US$73,500 		5,000 -33.2% 14.70 US$73,500
2013-02-26 2013-02-25 PlS Planned sale Lovejoy Chandra D

VP of Regulatory Affairs

Officer
1,993 -100.0%
9.70
US$19,332 		1,993 -100.0% 9.70 US$19,332
2013-02-26 2013-02-25 PlS Planned sale Lovejoy Chandra D

VP of Regulatory Affairs

Officer
109 -100.0%
9.70
US$1,057 		109 -100.0% 9.70 US$1,057
2013-02-20 2013-02-19 PlS Planned sale Ritter Allen R

VP of Manufacturing/CMC

Officer
500 -14.4%
10.03
US$5,015 		500 -14.4% 10.03 US$5,015
2013-01-29 2013-01-25 PlS Planned sale Lovejoy Chandra D

VP of Regulatory Affairs

Officer
1,659 -100.0%
9.56
US$15,860 		1,659 -100.0% 9.56 US$15,860
2013-01-29 2013-01-25 PlS Planned sale Lovejoy Chandra D

VP of Regulatory Affairs

Officer
443 -100.0%
9.56
US$4,235 		443 -100.0% 9.56 US$4,235
2013-01-29 2013-01-25 PlS Planned sale Lovejoy Chandra D

VP of Regulatory Affairs

Officer
107 -100.0%
9.56
US$1,023 		107 -100.0% 9.56 US$1,023
2012-12-28 2012-12-26 PlS Planned sale Lovejoy Chandra D

VP of Regulatory Affairs

Officer
2,102 -100.0%
9.05
US$19,023 		2,102 -100.0% 9.05 US$19,023
2012-12-28 2012-12-26 PlS Planned sale Lovejoy Chandra D

VP of Regulatory Affairs

Officer
107 -100.0%
9.05
US$968 		107 -100.0% 9.05 US$968
2012-11-27 2012-11-26 PlS Planned sale Lovejoy Chandra D

VP of Regulatory Affairs

Officer
1,926 -100.0%
8.72
US$16,795 		1,926 -100.0% 8.72 US$16,795
2012-11-27 2012-11-26 PlS Planned sale Lovejoy Chandra D

VP of Regulatory Affairs

Officer
283 -100.0%
8.72
US$2,468 		283 -100.0% 8.72 US$2,468
2012-10-29 2012-10-25 PlS Planned sale Lovejoy Chandra D

VP of Regulatory Affairs

Officer
2,209 -100.0%
9.71
US$21,449 		2,209 -100.0% 9.71 US$21,449
2012-10-01 2012-09-28 S Sale Low Philip S

Chief Science Officer

Executive Director
34,000 -8.1%
9.99
US$339,810 		34,000 -8.1% 9.99 US$339,810
2012-09-27 2012-09-25 PlS Planned sale Lovejoy Chandra D

VP of Regulatory Affairs

Officer
2,209 -100.0%
10.28
US$22,709 		2,209 -100.0% 10.28 US$22,709
2012-08-17 2012-08-16 S Sale Leamon Christopher P

Vice President of Research

Officer
10,000 -39.9%
9.65
US$96,535 		10,000 -39.9% 9.65 US$96,535
2012-06-07 2012-06-06 S Sale HANHAM ANN Non-Executive Director
24,181 -27.4%
6.60
US$159,674 		24,181 -27.4% 6.60 US$159,674
2012-06-07 2012-06-06 S Sale HANHAM ANN Non-Executive Director
290,719 -27.4%
6.60
US$1,919,705 		290,719 -27.4% 6.60 US$1,919,705
2012-06-07 2012-06-05 S Sale HANHAM ANN Non-Executive Director
783 -0.9%
6.60
US$5,170 		783 -0.9% 6.60 US$5,170
2012-06-07 2012-06-05 S Sale HANHAM ANN Non-Executive Director
9,417 -0.9%
6.60
US$62,180 		9,417 -0.9% 6.60 US$62,180
2012-05-18 2012-05-16 S Sale HANHAM ANN Non-Executive Director
2,142 -2.3%
6.65
US$14,246 		2,142 -2.3% 6.65 US$14,246
2012-05-18 2012-05-16 S Sale HANHAM ANN Non-Executive Director
25,758 -2.3%
6.65
US$171,306 		25,758 -2.3% 6.65 US$171,306
2012-05-16 2012-05-15 S Sale HANHAM ANN Non-Executive Director
3,071 -3.3%
6.68
US$20,510 		3,071 -3.3% 6.68 US$20,510
2012-05-16 2012-05-15 S Sale HANHAM ANN Non-Executive Director
36,929 -3.3%
6.68
US$246,638 		36,929 -3.3% 6.68 US$246,638
2012-05-16 2012-05-14 S Sale HANHAM ANN Non-Executive Director
8,215 -8.0%
6.94
US$56,974 		8,215 -8.0% 6.94 US$56,974
2012-05-16 2012-05-14 S Sale HANHAM ANN Non-Executive Director
98,785 -8.0%
6.94
US$685,113 		98,785 -8.0% 6.94 US$685,113
2011-12-22 2011-12-21 B Purchase SANDERLING VENTURES MANAGEMENT V Large shareholder
2,200 +6.7%
3.16
US$6,952 		2,200 +6.7% 3.16 US$6,952
2011-12-22 2011-12-21 B Purchase Sanderling Venture Partners V, LP Large shareholder
217,800 +33.3%
3.16
US$688,248 		217,800 +33.3% 3.16 US$688,248
Explore more

More insider trading research around Endocyte Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America